North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others),

PrintEmail
July 2022 - 100 Pages - From $2,980
(Excel Data Sheet: $1,500)
Description

The report cover may be different from the image shown.

  • The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order. 
  • To learn more about the report, please Download Free Sample Pages and Download Excel Datasheet Sample. The report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
  • Please Contact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
  • For details about the license types, please refer to our Terms of Service 
Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

North America pharmaceutical analytical testing outsourcing market is projected to grow by 7.5% annually in the forecast period and reach $ 6,029.2 million by 2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities.
Highlighted with 24 tables and 47 figures, this 100-page report “North America Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America pharmaceutical analytical testing outsourcing market in every aspect of the classification from perspectives of Service Type, Product Type, End User, Organization Size, and Country.

Based on Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Bioanalytical Testing
o Clinical Testing
o Non-clinical Testing
• Method Development and Validation
o Extractable & Leachable
o Impurity Method
o Technical Consulting
o Other Methods
• Stability Testing
o Drug Substances Testing
o Accelerated Stability Testing
o Photostability Testing
o Other Stability Testings
• Other Services

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Raw Materials & Additives
• Active Pharmaceutical Ingredients (APIs)
• Finished Products

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Other End Users

By Organization Size, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• SMEs
• Large Enterprises

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Service Type, End User and Organization Size over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Boston Analytical, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Exova Group PLC
Intertek Pharmaceutical Services
Laboratory Testing Inc.
Pace Analytical Services LLC
Pharmaceutical Product Development, LLC
SGS SA
Steris PLC
Tentamus
Toxikon Inc.
West Pharmaceutical Services Inc.
WuXi AppTec, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of North America Market by Service Type 39
3.1 Market Overview by Service Type 39
3.2 Bioanalytical Testing 41
3.2.1 Clinical Testing 42
3.2.2 Non-clinical Testing 43
3.3 Method Development and Validation 44
3.3.1 Extractable & Leachable 46
3.3.2 Impurity Method 47
3.3.3 Technical Consulting 48
3.3.4 Other Methods 49
3.4 Stability Testing 50
3.4.1 Drug Substances Testing 52
3.4.2 Accelerated Stability Testing 53
3.4.3 Photostability Testing 54
3.4.4 Other Stability Testings 55
3.5 Other Services 56
4 Segmentation of North America Market by Product Type 57
4.1 Market Overview by Product Type 57
4.2 Raw Materials & Additives 59
4.3 Active Pharmaceutical Ingredients (APIs) 60
4.4 Finished Products 61
5 Segmentation of North America Market by End User 62
5.1 Market Overview by End User 62
5.2 Pharmaceutical & Biopharmaceutical Companies 64
5.3 Contract Manufacturing Organizations (CMOs) 65
5.4 Other End Users 66
6 Segmentation of North America Market by Organization Size 67
6.1 Market Overview by Organization Size 67
6.2 SMEs 69
6.3 Large Enterprises 70
7 North America Market 2021-2031 by Country 71
7.1 Overview of North America Market 71
7.2 U.S. 74
7.3 Canada 77
7.4 Mexico 79
8 Competitive Landscape 81
8.1 Overview of Key Vendors 81
8.2 New Product Launch, Partnership, Investment, and M&A 84
8.3 Company Profiles 85
Boston Analytical, Inc. 85
Charles River Laboratories International, Inc. 87
Eurofins Scientific SE 88
Exova Group PLC 89
Intertek Pharmaceutical Services 90
Laboratory Testing Inc. 91
Pace Analytical Services LLC 92
Pharmaceutical Product Development, LLC 93
SGS SA 94
Steris PLC 95
Tentamus 96
Toxikon Inc. 97
West Pharmaceutical Services Inc. 98
WuXi AppTec, Inc. 99
RELATED REPORTS 100

List of Tables:

Table 1. Snapshot of North America Pharmaceutical Analytical Testing Outsourcing Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 20
Table 3. Worldwide Total Number of Registered Clinical Trials 27
Table 4. Main Product Trends and Market Opportunities in North America Pharmaceutical Analytical Testing Outsourcing Market 31
Table 5. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 39
Table 6. North America Pharmaceutical Analytical Testing Outsourcing Market: Bioanalytical Testing by Type, 2021-2031, $ mn 41
Table 7. North America Pharmaceutical Analytical Testing Outsourcing Market: Method Development and Validation by Type, 2021-2031, $ mn 45
Table 8. North America Pharmaceutical Analytical Testing Outsourcing Market: Stability Testing by Type, 2021-2031, $ mn 51
Table 9. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type, 2021-2031, $ mn 57
Table 10. North America Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 62
Table 11. North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 67
Table 12. North America Pharmaceutical Analytical Testing Outsourcing Market by Country, 2021-2031, $ mn 72
Table 13. U.S. Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 76
Table 14. U.S. Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 76
Table 15. U.S. Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 76
Table 16. Canada Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 78
Table 17. Canada Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 78
Table 18. Canada Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 78
Table 19. Mexico Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, $ mn 80
Table 20. Mexico Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, $ mn 80
Table 21. Mexico Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, $ mn 80
Table 22. Boston Analytical, Inc.: Company Snapshot 85
Table 23. Boston Analytical, Inc.: Business Segmentation 86
Table 24. Boston Analytical, Inc.: Product Portfolio 86

 

 

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn 18
Figure 5. Impact of COVID-19 on Business 21
Figure 6. Primary Drivers and Impact Factors of North America Pharmaceutical Analytical Testing Outsourcing Market 23
Figure 7. World Pharmaceutical CDMO Market, 2019-2030, $ bn 26
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 26
Figure 9. Primary Restraints and Impact Factors of North America Pharmaceutical Analytical Testing Outsourcing Market 28
Figure 10. Investment Opportunity Analysis 32
Figure 11. Porter’s Fiver Forces Analysis of North America Pharmaceutical Analytical Testing Outsourcing Market 35
Figure 12. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type, 2021-2031, % of Revenue 40
Figure 13. North America Addressable Market Cap in 2022-2031 by Service Type, Value ($ mn) and Share (%) 40
Figure 14. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Bioanalytical Testing, 2021-2031, $ mn 41
Figure 15. North America Pharmaceutical Analytical Testing Outsourcing Market by Bioanalytical Testing: Clinical Testing, 2021-2031, $ mn 42
Figure 16. North America Pharmaceutical Analytical Testing Outsourcing Market by Bioanalytical Testing: Non-clinical Testing, 2021-2031, $ mn 43
Figure 17. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Method Development and Validation, 2021-2031, $ mn 44
Figure 18. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Extractable & Leachable, 2021-2031, $ mn 46
Figure 19. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Impurity Method, 2021-2031, $ mn 47
Figure 20. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Technical Consulting, 2021-2031, $ mn 48
Figure 21. North America Pharmaceutical Analytical Testing Outsourcing Market by Method Development and Validation: Other Methods, 2021-2031, $ mn 49
Figure 22. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Stability Testing, 2021-2031, $ mn 50
Figure 23. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Drug Substances Testing , 2021-2031, $ mn 52
Figure 24. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Accelerated Stability Testing, 2021-2031, $ mn 53
Figure 25. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Photostability Testing, 2021-2031, $ mn 54
Figure 26. North America Pharmaceutical Analytical Testing Outsourcing Market by Stability Testing: Other Stability Testings, 2021-2031, $ mn 55
Figure 27. North America Pharmaceutical Analytical Testing Outsourcing Market by Service Type: Other Services, 2021-2031, $ mn 56
Figure 28. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type, 2021-2031, % of Sales Revenue 58
Figure 29. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 58
Figure 30. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Raw Materials & Additives, 2021-2031, $ mn 59
Figure 31. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Active Pharmaceutical Ingredients (APIs), 2021-2031, $ mn 60
Figure 32. North America Pharmaceutical Analytical Testing Outsourcing Market by Product Type: Finished Products, 2021-2031, $ mn 61
Figure 33. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by End User, 2021-2031, % of Sales Revenue 63
Figure 34. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 63
Figure 35. North America Pharmaceutical Analytical Testing Outsourcing Market by End User: Pharmaceutical & Biopharmaceutical Companies, 2021-2031, $ mn 64
Figure 36. North America Pharmaceutical Analytical Testing Outsourcing Market by End User: Contract Manufacturing Organizations (CMOs), 2021-2031, $ mn 65
Figure 37. North America Pharmaceutical Analytical Testing Outsourcing Market by End User: Other End Users, 2021-2031, $ mn 66
Figure 38. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size, 2021-2031, % of Revenue 68
Figure 39. North America Addressable Market Cap in 2022-2031 by Organization Size, Value ($ mn) and Share (%) 68
Figure 40. North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size: SMEs, 2021-2031, $ mn 69
Figure 41. North America Pharmaceutical Analytical Testing Outsourcing Market by Organization Size: Large Enterprises, 2021-2031, $ mn 70
Figure 42. Breakdown of North America Pharmaceutical Analytical Testing Outsourcing Market by Country, 2021 and 2031, % of Revenue 72
Figure 43. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 73
Figure 44. U.S. Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn 75
Figure 45. Canada Pharmaceutical Analytical Testing Outsourcing Market, 2021-2031, $ mn 77
Figure 46. Pharmaceutical Analytical Testing Outsourcing Market in Mexico, 2021-2031, $ mn 79
Figure 47. Growth Stage of North America Pharmaceutical Analytical Testing Outsourcing Industry over the Forecast Period 81

 

 
 
 

Reviews

There are yet no reviews for this product.